Publications by authors named "Lauren Musso"

Claim this Profile
C
Corrigendum to "OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer" [Gynecol Oncol 2025 Jun 197 182-191].
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Lauren Musso

Gynecol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OVATION-2: A randomized phase I/II study evaluating the safety and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in patients newly-diagnosed with advanced epithelial ovarian cancer.
Premal H Thaker, Debra L Richardson, Andrea R Hagemann, Robert W Holloway, Mark Reed, Lauren Musso

Gynecol Oncol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Historic Clinical Trial External Control Arm Provides Actionable GEN-1 Efficacy Estimate Before a Randomized Trial.
Xiang Yin, Ruthanna Davi, Elizabeth B Lamont, Premal H Thaker, William H Bradley, Lauren Musso

JCO Clin Cancer Inform· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GEN-1 in Combination with Neoadjuvant Chemotherapy for Patients with Advanced Epithelial Ovarian Cancer: A Phase I Dose-escalation Study.
Premal H Thaker, William H Bradley, Charles A Leath, Camille Gunderson Jackson, Nicholas Borys, Lauren Musso

Clin Cancer Res· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis